SARS-CoV-2 infection is not associated with the emergence of monoclonal gammopathies

Cecilia Simonini1,2, Patrizia Natali1, Tommaso Pirotti1

  • 1Department of Laboratory Medicine and Pathology, AUSL/AOU, Modena, Italy.

Abstract

Insights

SARS-CoV-2 infection does not correlate with monoclonal component (MC) development. However, MC persistence was higher in SARS-CoV-2-negative patients, suggesting viral hyperstimulation of the immune system.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Hematology

Background:

  • Activated plasma cells produce antibodies, potentially leading to monoclonal components (MC) detectable by serum protein electrophoresis (SPEP).
  • Investigating the link between SARS-CoV-2 infection and MC development is crucial for understanding immune responses.

Purpose of the Study:

  • To determine if there is a correlation between SARS-CoV-2 infection and the development of monoclonal components (MC).
  • To assess the persistence of MC in patients following SARS-CoV-2 infection.

Main Methods:

  • Serum protein electrophoresis (SPEP) was performed on 786 hospitalized patients between March 2020 and March 2022.
  • Patients were categorized as SARS-CoV-2 positive or negative via RT-PCR.
  • MC persistence and new occurrences were tracked during follow-up, with comparisons made using chi-square analysis.

Main Results:

  • Monoclonal components (MC) were found in 12% of all patients; 28.7% of these had SARS-CoV-2.
  • No significant correlation was observed between MC development and SARS-CoV-2 infection (p=0.173).
  • A higher risk of MC persistence was noted in SARS-CoV-2-negative patients compared to SARS-CoV-2-positive patients (HR=0.591, p=0.05).

Conclusions:

  • The presence of MC during SARS-CoV-2 infection is likely due to general humoral immune system hyperstimulation, common in viral infections.
  • SARS-CoV-2 infection itself does not appear to be a direct cause of MC development.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.1K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K